The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

MYPRAVAC SUISSuspension for injection

50 percent Suspension for injection

Laboratorios Hipra S.A.VPA10846/004/001

Main Information

Trade NameMYPRAVAC SUISSuspension for injection
Active SubstancesInactivated Mycoplasma hyopneumoniae strain J
Strength50 percent
Dosage FormSuspension for injection
Licence HolderLaboratorios Hipra S.A.
Licence NumberVPA10846/004/001

Group Information

ATC CodeQI09AB13 mycoplasma
Therapeutic ClassImmunological - Inactivated Vaccine


Licence Issued02/05/2003
Legal StatusLM: Licensed Merchant as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back